CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net (loss) income	$ 500	$ 2,468	$ 1,791
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Loss from discontinued operations			32
Net (gain) loss from securities transactions	(1,206)	926	(570)
Purchases of securities	(2,158)	(1,945)	(4,948)
Proceeds from Sale of Securities	4,172	4,040	3,648
Payments to cover securities sold, not yet purchased	(2,775)	(2,336)	(938)
Proceeds from securities sold, not yet purchased	4,025	2,913	1,523
Changes in receivables and payables relating to securities transactions	(2,035)	(1,880)	(220)
Changes in derivative assets and liabilities	321	(433)	1,181
(Gain) loss on disposition of assets, net	(141)	17	(253)
Depreciation and amortization	517	510	519
Deferred taxes	(168)	(49)	(89)
Inventory write-down	59	59
Other, net	50	12	18
Changes in other operating assets and liabilities:
Accounts receivable, net	(110)	28	(33)
Inventories	(83)	147	(20)
Other assets	24	30	356
Accounts payable	77	(162)	145
Accrued expenses and other liabilities	252	175	(20)
Net cash provided by (used in) operating activities	321	(416)	(1,460)
Cash flows from investing activities:
Capital expenditures	(305)	(199)	(250)
Turnaround expenditures	(5)	(159)	(38)
Acquisition of businesses, net of cash acquired	(20)	(8)	(39)
Purchases of investments		(337)	(50)
Proceeds from sale of investments	445	98	458
Proceeds from disposition of businesses and assets	414	25	505
Other, net	(1)	(1)
Net cash provided by (used in) investing activities	528	(581)	586
Cash flows from financing activities:
Investment segment contributions from non-controlling interests	74	13	220
Partnership contributions	835	102	55
Partnership distributions	(134)	(526)	(112)
Purchase of additional interests in consolidated subsidiaries			(241)
Dividends and distributions to non-controlling interests in subsidiaries	(101)	(36)	(119)
Proceeds from Holding Company senior unsecured notes	1,214	866	2,507
Repayments of Holding Company senior unsecured notes	(1,205)	(1,350)	(1,700)
Proceeds from subsidiary borrowings	1,165	1,946	810
Repayments of subsidiary borrowings	(1,545)	(1,644)	(847)
Other, net	(10)	(24)	(7)
Net cash provided by (used in) financing activities	293	(653)	566
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents	3	(4)	(2)
Add back change in cash and restricted cash of assets held for sale			(83)
Net increase (decrease) in cash and cash equivalents and restricted cash and restricted cash equivalents	1,145	(1,654)	(393)
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period	3,291	4,945	5,338
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period	$ 4,436	$ 3,291	$ 4,945